Omalizumab monotherapy for bee sting and unprovoked "anaphylaxis" in a patient with systemic mastocytosis and undetectable specific IgE.
Kontou-Fili
Kalliopi
K
Filis
Christos I
CI
Voulgari
Christina
C
Panayiotidis
Panayiotis G
PG
D000707:Anaphylaxis / Q000517:prevention & control*; D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001516:Bees; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D007299:Insect Bites and Stings / Q000188:drug therapy*; D008297:Male; D034721:Mastocytosis, Systemic / Q000276:immunology*; D008875:Middle Aged; D000069444:Omalizumab
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E